Cellular therapies and biotherapies are growing areas of medicine that are transforming patient care. AABB works with the cellular therapies community to drive policies that ensure patient access, advance research, increase the supply and safety biological products, and expand coverage for these transformative therapies.
REGULATORY UPDATE: FDA Releases 2023 Guidance Agenda
January 31, 2023
On-Demand CABP Exam Opens Feb. 15
January 31, 2023
AABB/ISCT Joint Working Group Releases GTP Interpretative Tool
January 25, 2023